| عنوان البحث | ملخص البحث |
| Factors associated with improved glycemic control by direct-acting antiviral agent treatment in Egyptian type 2 diabetes mellitus patients with chronic hepatitis C genotype 4 | |
| Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot | |
| Helicobacter pylori and non‐alcoholic fatty liver disease: A new enigma? | |
| Assessment of serum magnesium level in patients with liver cirrhosis
| |
| The relationship between serum dipeptidyl peptidase-4 enzyme and nonalcoholic fatty liver disease in diabetic and nondiabetic patients | |
| Study of endotoxin in patients with liver cirrhosis with and without hepatic encephalopathy | |
| Do we need to screen for de-novo diabetes mellitus in chronic hepatitis C patients after a sustained virological response? | |
| Serum leptin and homeostasis model assessment-IR as novel predictors of early liver fibrosis in chronic hepatitis B virus infection | |
